Skip to main content

Advertisement

Log in

In vitro effects of vitamin D3 metabolites on rat calvaria cAMP content

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Results from in vitro works suggest that 1,25- and 24,25-dihydroxyvitamin D3 (1,25-(OH)2D3 and 24,25-(OH)2D3) act on bone via different mechanisms. The present investigation was performed to study the effect of these two metabolites and of their precursor 25-hyxdroxyvitamin D3 (25-(OH)D3) on bone cAMP content in vitro. Rats' paired half calvaria were incubated under sterile conditions with one vitamin D3 derivative (10−13 to 10−9 M) or with ethanol (0.005 ml for 15 min to 24 h in 1 ml medium containing 0, 0.2, 1, 2, or 3 mM calcium. In some experiments: (a) cycloheximide (10−5M) was added simultaneously with the vitamin D3 metabolites; (b) 1–84 bPTH (5 × 10−8 M) was added for 5 or 15 min at the end of the 24 h incubation. Calvaria were immersed in 1 ml TCA 5% 4°C and homogenized. The cAMP was extracted with diethylether and measured by a competitive protein binding assay. Results bring further evidence for a particular effect of low doses of 24,25-(OH)2D3 (10−9 to 10−12M) and of 25-(OH)D3 (10−9 to 10−11M) on bone, different from that of 1,25-(OH)2D3: cAMP content was higher in 24,25-(OH)2D3- or 25-(OH)D3-treated and lower in 1,25-(OH)2D3-treated calvaria than in ethanol-treated ones with 1 mM calcium. The 1,25-(OH)2D3 effect persisted in calcium-free medium whereas 25-(OH)D3 and 24,25-(OH)2D3 effects could not be observed with 0 mM nor with 3 mM calcium. The required duration of the preincubation (over 1 h) as well as the inhibitory action of cycloheximide may suggest an involvement of protein synthesis in the vitamin D3 metabolites effects. Neither 1,25-(OH)2D3 nor 24,25-(OH)2D3 affected the PTH-induced increase in bone cAMP content.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chase, L.R., Fedak, S.A., Aurbach, G.D.: Activation of skeletal adenyl cyclase by parathyroid hormone in vitro, Endocrinology84:761–768, 1969

    CAS  PubMed  Google Scholar 

  2. Herrmann-Erlee, M.P.M., Konijn, T.M.: Effect of parathyroid extract on cyclic AMP content of embryonic mouse calvaria, Nature227:177–178, 1970

    Article  CAS  PubMed  Google Scholar 

  3. Chase, L.R., Aurbach, G.D.: The effect of parathyroid hormone on the concentration of adenosine 3′5′-monophosphate in skeletal tissue in vitro, J. Biol. Chem.245:1520–1526, 1970

    CAS  PubMed  Google Scholar 

  4. Raisz, L.G., Trummel, C.L., Holick, M.F., DeLuca, H.F.: 1,25-Dihydroxycholecalciferol: A potent stimulator of bone resorption in tissue culture, Science175:768–769, 1972

    CAS  PubMed  Google Scholar 

  5. Reynolds, J.J., Holick, M.F., DeLuca, H.F.: The role of vitamin D metabolites in bone resorption, Calcif. Tissue Res.12:295–301, 1973

    Article  CAS  PubMed  Google Scholar 

  6. Stern, P.H., Hamstra, A.J., DeLuca, H.F., Bell, N.H.: Bone organ culture bioassay for determination of 1,25-(OH)2D. In A.W. Norman, K. Schaefer, J.W. Cobburn, H.F. DeLuca, D. Fraser, H.G. Grigoleit, and D.V. Herrath (eds.): Vitamin D: Biochemical, Chemical and Clinical Aspects related to Calcium Metabolism, pp. 531–540. Walter de Gruyter, Berlin, 1977

    Google Scholar 

  7. Mellow, A.M., Stosich, G.V., Stern, P.H.: Dissociation of specific binding of 25-(OH)D3 and resorption in fetal rat bones. Mol. Cell. Endocrinol.10:149–158, 1978

    Article  CAS  PubMed  Google Scholar 

  8. Wong, G.L., Luben, R.A., Cohn, D.V.: 1,25-Dihydroxycholecalciferol and parathormone: Effects on isolated osteoclast-like cells, Science197:663–665, 1977

    CAS  PubMed  Google Scholar 

  9. Yamamoto, I., Dokoh, S., Fukunaga, M., Morita, R., Torizuka, K.: Non specific suppression of increase in cyclic AMP in cultured cells after exposure to vitamin D metabolites. In A.W. Norman, K. Schaefer, H.G. Grigoleit, D. Von Herrath, and E. Ritz (eds.): Proceedings of the Fourth Workshop on Vitamin D, Berlin, February 1979, Walter de Gruyter, Berlin (in press)

  10. Lieberherr, M., Garabédian, M., Guillozo, H., Bailly du Bois, M., Balsan, S.: Interaction of 24,25-Dihydroxyvitamin D3 and parathyroid hormone on bone enzymes in vitro, Calcif. Tissue Int.27:47–52, 1979

    CAS  PubMed  Google Scholar 

  11. Dziak, R.: Effects of vitamin D3 metabolites on bone cell calcium transport, Calcif. Tissue Int.26:65–70, 1978

    Article  CAS  Google Scholar 

  12. Dziak, R., Stern, P.H.: Calcium transport in isolated bone cells. III. Effects of parathyroid hormone and cyclic 3′5′-AMP, Endocrinology97:1281–1287, 1975

    Article  CAS  PubMed  Google Scholar 

  13. Reynolds, J.J.: The effect of ascorbic acid on the growth of chick bone rudiments in chemically defined medium, Exp. Cell Res.42:178–188, 1966

    Article  CAS  PubMed  Google Scholar 

  14. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the Folin phenol reagent, J. biol. Chem.193:265–275, 1951

    CAS  PubMed  Google Scholar 

  15. Gilman, A.G.: A protein-binding assay for adenosine 3′5′-cyclic monophosphate, Proc. Natl. Acad. Sci. U.S.A.67:305–312, 1970

    CAS  PubMed  Google Scholar 

  16. Ramachandran, J.: A new simple method for separation of adenosine 3′5′-cyclic monophosphate from other nucleotides and its use in the assay of adenyl cyclase, Anal. Biochem.43:227–239, 1971

    Article  CAS  PubMed  Google Scholar 

  17. Kream, B.E., Jose, M., Yamada, S., DeLuca, H.F.: A specific high affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone, Science197:1086–1088, 1975

    Google Scholar 

  18. Garabedian, M., Lieberherr, M., Nguyen, T.M., Corvol, M.T., Bailly du Bois, M., Balsan, S.: The in vitro production and activity of 24,25-dihydroxycholecalciferol in cartilage and calvarium, Clin. Orthop. Rel. Res.135:241–248, 1978

    CAS  Google Scholar 

  19. Beaulieu, E.E.: Cell membrane, a target for steroid hormones, Mol. Cell Endocrinol.12:247–254, 1978

    Article  Google Scholar 

  20. Mahgoub, A., Sheppard, H.: Early effect of 25-hydroxycholecalciferol (25-(OH)D3) and 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) on the ability of parathyroid hormone (PTH) to elevate cyclic AMP of intact bone cells, Biochem. Biophys. Res. Commun.62:901–907, 1975

    Article  CAS  PubMed  Google Scholar 

  21. Peck, W.A., Dowling, J.: Failure of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) to modify cyclic AMP levels in parathyroid hormone treated and untreated bone cells, Endocrinol. Res. Commun.3:157–166, 1976

    Article  CAS  Google Scholar 

  22. Gebauer, U., Fleisch, H.: Effect of 1,25-dihydroxycholecalciferol on adenosine 3′5′-cyclic monophosphate production in calvaria of mice, Calcif. Tissue Res.25:223–225, 1978

    Article  CAS  PubMed  Google Scholar 

  23. Herrmann-Erlee, M.P.M., Gaillard, P.J., Nijweide, P.J.: Studies on the interrelation between the effects of PTE, PGE and 1,25-(OH)2D3 on embryonic bone in vitro, Calcif. Tissue Res. [Suppl.]27:A16, 1979

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lieberherr, M., Garabédian, M., Guillozo, H. et al. In vitro effects of vitamin D3 metabolites on rat calvaria cAMP content. Calcif Tissue Int 30, 209–216 (1980). https://doi.org/10.1007/BF02408630

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02408630

Key words

Navigation